Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × lutetium Lu 177 dotatate × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 8 Gastro-enteropancreatic neuroendocrine tumor 3 Pheochromocytoma 2 Paraganglioma 2 Meningioma 2 Adenoma, Islet Cell 2 Somatostatin Receptor-positive Neuroendocrine Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Hypertension 1 Glioblastoma 1 Extensive Stage Small Cell Lung Cancer 1 Disease Progression 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

fludarabine 3 Cyclophosphamide 3 fludarabine phosphate 2 Sirolimus 2 Etoposide 2 Cisplatin 2 Carboplatin 2 tremelimumab 1 pralsetinib 1 pembrolizumab 1 etoposide phosphate 1 durvalumab 1 cabozantinib 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Proton Therapy 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Busulfan 1 Bleomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡